Share

BPA Exposure Leads to Abnormal Estrous Cycle and Folliculogenesis, Mouse Study Finds

Exposure to bisphenol A (BPA), even at environmentally low doses, disrupts the preovulatory luteinizing hormone (LH) surge and leads to abnormal estrous cycle and folliculogenesis, according to a study recently published in Endocrinology. This disruption is reversible following adult exposure, but it persists into adulthood after neonatal exposure. Researchers led by David Lopez-Rodriguez, MSc, at the neuroendocrinology...
Share

Endocrine Society Applauds EU Green Deal Resolution

The Endocrine Society praised the European Parliament resolution in response to the European Union’s “Green Deal”— a plan to invest more than €1 trillion in environmental initiatives, including important provisions to protect people from exposure to endocrine-disrupting chemicals (EDCs). Launched on December 11, the Green Deal contains a commitment to produce a chemicals strategy for...
Share

AFTERMATH: What Happens Next After Thyroid Cancer Treatment?

EN_0120_US_cover The challenges of managing thyroid cancer patients include regulating their hormone replacement therapy and monitoring for recurrence. Here, we highlight an upcoming ENDO 2020 session that details the issues in treating patients post-thyroid cancer therapy. Thyroid cancer patients generally have an excellent prognosis but require careful management to optimize their care. Some strategies for optimizing...
Share

Endocrine Society Awards Baxter Prize to Daniel J. Drucker

Drucker headshot Researcher Daniel J. Drucker, MD, has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for his contributions to diabetes treatment, the Society announced today. Drucker’s research has contributed greatly to the understanding and treatment of diabetes over the last 25 years. He discovered new mechanisms of hormone action enabling the development of...
Share

ENDO 2020: San Francisco Treats

SanFranLoRez ENDO 2020 is heading west so Endocrine News is hoping to encourage you to attend the most important meeting of endocrinology scientists and clinicians from around the world by tempting you with a few highlights of this year’s host city: San Francisco. San Francisco is known for its cable cars, iconic bridge, and for being...
Share

Review Examines Optimal Care for Patients with 46,XY Differences of Sex Development

Treating patients with 46,XY differences of sex development (DSD) will require interdisciplinary healthcare teams trained to care for patients and their families, according to a paper recently published in Endocrine Reviews. The review, by Amy B. Wisniewski, of Oklahoma State University in Stillwater, et al., points out that DSD are a heterogenous group of congenital...
Share

Remembering Jean E. Rivier, PhD (1941 – 2019)

Jean Rivier Jean Rivier was a chemist both in training and spirit, but by isolating and characterizing many then-undiscovered peptide hormones, and providing the synthetic peptide tools critical to experimental biology to study them, he became a pioneer of our modern understanding of the biological roles of peptides in regulating nearly all physiologic systems ranging from endocrinology...